C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor

Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
10/2002
10/30/2002	EP1252176A2 Nucleic acids, proteins, and antibodies
10/30/2002	EP1252107A1 Method for treating bacterial effluents containing at least a gordonia terrae cip i-2194 ether
10/30/2002	EP1251835A2 Closure of bacterial ghosts
10/30/2002	EP1251744A1 Enhanced production of lipids containing polyenoic fatty acids by high density cultures of eukaryotic microbes in fermentors
10/30/2002	EP0699076B1 Otitis media vaccine
10/30/2002	CN1377422A Improved fermentation process
10/30/2002	CN1377415A 疫苗组合物 Vaccine composition
10/30/2002	CN1377412A Polypeptides
10/30/2002	CN1377411A BASB 119 polypeptide and polynucleotide from noraxella catarrhalis
10/30/2002	CN1377410A Nucleic acids and proteins from group B streptoccus
10/30/2002	CN1377409A MEG-1 protein
10/30/2002	CN1377408A The PRV-1 gene and use thereof
10/30/2002	CN1377370A C-peptide for the improved production of insulin and insulin analogues
10/30/2002	CN1377364A Resticidal macrolides
10/30/2002	CN1377231A Fermented milk drinks and foods and process for producing the same
10/30/2002	CN1376778A Process for preparing human insulin by means of transgenic fungus
10/30/2002	CN1376777A Process for culturing microalga cells by combination of supplementing carbon by solvent with collecting them by air floating
10/30/2002	CN1376513A Cordyceps powder and its preparing process
10/30/2002	CN1376498A Process for further processing Chinese-medicinal material
10/30/2002	CN1376401A Detoxicated pencillim dregs, its preparing process and application of its somatic protein in feed
10/30/2002	CN1093379C Enzyme feed additive and animal feed including it
10/29/2002	US6472587 Production of a 5-(2-chloro-4-(trifluoromethyl)phenoxy)-2-nitrobenzoic acid or 7-chloro-3-methyllquinoline-8-carboxylic acid-tolerant plant by expressing an exogenous 5-(2-chloro-4-(trifluoromethyl)phenoxy)-2-nitrobenzoic acid or 7-chloro-3-methyllquinoline-8-carboxylic acid-binding antibody in the plant
10/29/2002	US6472519 Plasmodium falciparum antigens inducing protective antibodies
10/29/2002	US6472518 Invasion associated genes from Neisseria meningitidis serogroup B
10/29/2002	US6472513 Human gene RecQ4 encoding helicase
10/29/2002	US6472367 Compounds and methods for modulating OB-cadherin mediated cell adhesion
10/29/2002	US6472213 Shuttle vectors for the introduction of DNA into mycobacteria and utilization of such bacteria as vaccines
10/29/2002	US6472211 Amplification of transcription of preferential genes; obtain cell, incubate with regulatory protein, monitor propagation of cells
10/29/2002	US6472196 Amino acid sequence of L-phenylalanine ammonia-lyase
10/29/2002	US6472195 Human kallikrein
10/29/2002	US6472193 Capable of specifically hydrolyzing lysophosphatidic acid (lpa) which is useful for elucidation of the metabolic pathway of lpa, and also for diagnosis and treatment of various diseases; a protein encoded by specific dna
10/29/2002	US6472191 Introducing into a host microorganism a recombinant dna which comprises a vector which can replicate in host microorganism and dna fragment ligated to a vecto, form a transformant which produces a toluene monooxygenase encoded by dna
10/29/2002	US6472189 Esterase gene and its use
10/29/2002	US6472183 Immunity against Actinobacillus pleuropneumoniae's RTX toxins APX
10/29/2002	US6472180 A polynucleotide which encodes a truncated fragment of the hcv ns3 (hepatitis c virus)ns3 protein helicase fragment, such truncated fragment retaining helicase activity and having about 50 amino acids of carboxy terminus deleted
10/29/2002	US6472179 Nucleotide sequences coding fusion protein for use in the treatment of osteoporosis, cancers, and cachexia
10/29/2002	US6472178 Nucleic acids encoding a modified ciliary neurotrophic factor and method of making thereof
10/29/2002	US6472174 Polypeptides bind to the hek or elk receptor, the nucleic acids encoding such polypeptides; genetic engineering
10/29/2002	US6472172 DNA encoding a novel human inhibitor-of-apoptosis protein
10/29/2002	US6472169 Biocatalytic synthesis of shikimic acid
10/29/2002	US6472166 Incubating colony-forming units to form colonies, inoculating growth medium with the units, quantifying characteristics when exposed to the growth-altering agent, and evaluating the characteristics
10/29/2002	US6472158 Ustilipides, method for the production and the use thereof
10/29/2002	US6472152 Transformed salmonellas that are bioluminescent and the signal can be assayed as light production when induced by stresses
10/29/2002	US6471959 Human transferase
10/29/2002	US6471957 Canine IL-4 immunoregulatory proteins and uses thereof
10/29/2002	US6471741 Liquid soil enrichment microbial compositions
10/29/2002	CA2249014C Ds11 (kctc 0231bp), novel bacillus sp. strain and novel phytase produced by it
10/29/2002	CA2173102C Dna sequence coding for a bmp receptor
10/29/2002	CA2112374C Novel yeast strains for the production of xylitol
10/24/2002	WO2002084286A1 Screening method
10/24/2002	WO2002083945A2 Diagnosis and treatment of cancer: i
10/24/2002	WO2002083929A2 System and method for quantitating transcription factors
10/24/2002	WO2002083925A2 Papaya ringspot virus genes
10/24/2002	WO2002083907A1 Process for producing target polypeptide by using uspa
10/24/2002	WO2002083900A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/24/2002	WO2002083898A1 Full-length human cdnas encoding potentially secreted proteins
10/24/2002	WO2002083892A2 Mutants of desoxycytidine kinase having extended enzymatic activity
10/24/2002	WO2002083874A2 Endothelial cell expression patterns
10/24/2002	WO2002083873A2 Enzymes
10/24/2002	WO2002083872A2 Methods and products of cleaving ssdna using oligonucleotides to form restriction sites
10/24/2002	WO2002083870A2 Pufa polyketide synthase systems and uses thereof
10/24/2002	WO2002083869A2 Product and process for transformation of thraustochytriales microorganisms
10/24/2002	WO2002083866A2 Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions
10/24/2002	WO2002083859A2 Surface proteins of streptococcus pyogenes
10/24/2002	WO2002083858A2 Methods to inhibit viral replication
10/24/2002	WO2002083855A2 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
10/24/2002	WO2002083854A2 Antibodies to vla-1
10/24/2002	WO2002083853A2 Method for enhancing the translation and expression of recombinant proteins
10/24/2002	WO2002083847A2 Cdna encoding the human alpha2 delta4 calcium channel subunit
10/24/2002	WO2002083844A2 Compositions and methods for the production of betaine lipids
10/24/2002	WO2002083841A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/24/2002	WO2002083838A2 Elimination of endogenous porcine retrovirus
10/24/2002	WO2002083738A1 Cyclic single strand trispecific antibody
10/24/2002	WO2002083736A2 G-protein coupled receptor molecules and uses thereof
10/24/2002	WO2002083727A2 Nucleic acid sequences of hyperplasies and tumors of the thyroid
10/24/2002	WO2002083721A1 Protein cluster v
10/24/2002	WO2002083720A2 Intermediates and enzymes of the non-mevalonate isoprenoid pathway
10/24/2002	WO2002083712A2 Transporters and ion channels
10/24/2002	WO2002083711A2 Molecular mimetics of meningococcal b epitopes which elicit functionally active antibodies
10/24/2002	WO2002083709A2 Kinases and phosphatases
10/24/2002	WO2002083704A1 Vascular endothelial growth factor 2
10/24/2002	WO2002083576A1 A process for biochemical treatment of waste water using nano materials
10/24/2002	WO2002083262A1 Cell separation compositions and methods
10/24/2002	WO2002083179A2 Fusion proteins
10/24/2002	WO2002083062A2 Process for the production of piperidine derivatives with microorganisms
10/24/2002	WO2002082898A1 Novel endophytic fungi and methods of use
10/24/2002	WO2002062995A3 Human dorsal root receptor-like g protein-coupled receptor
10/24/2002	WO2002060931A3 A fimbria-like gene in bifidobacteria
10/24/2002	WO2002054873A3 Microbiological agents for the control of sea lice
10/24/2002	WO2002045524A3 Prolyl endoprotease from aspergillus niger
10/24/2002	WO2002044352A9 Bacteriolytic complex, method for producing said complex and strain for carrying out said method.
10/24/2002	WO2002042419A3 Cell culture apparatus and methods of use
10/24/2002	WO2002038739A3 Bacterial expression systems
10/24/2002	WO2002010425A3 Ascorbic acid production from yeasts
10/24/2002	WO2002006462A3 Methylated nucleotide regulation of upa gene expression
10/24/2002	WO2001073052A3 Thermophilic polymerase iii holoenzyme
10/24/2002	WO2001073038A3 Method for the biotechnological production of l-alaninol
10/24/2002	WO2001062793A9 Estrogen receptor beta variants and methods of detection thereof
10/24/2002	WO2001055337A3 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides
10/24/2002	WO2001049865A9 Fermentative production of ethanol by heterologous expression of a pyruvate decarboxylase gene in bacillus sp

1 ... 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 ... 1489